Jose G. Marin
Salamanca, CL, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 183 publications
Impact of CD44 alternative splicing on the response to anticancer drugs.
Journal: Biochemical pharmacology
Published: March 05, 2026
A transcriptomic five-gene signature for sorafenib response prediction in hepatocellular carcinoma: clinical promise and limitations.
Journal: Journal of gastrointestinal oncology
Published: February 08, 2026
Parenteral Berberine vs Cisplatin- Loaded Lipid Nanoparticles - Development, Characterisation, Comparative Safety Profiling and Cytotoxicity in Cholangiocarcinoma Cell Models.
Journal: Nanotechnology, science and applications
Published: January 14, 2026
Secreted chimeric proteins as a strategy to correct SOX17 deficiency and attenuate the malignant phenotype of cholangiocarcinoma cells: a proof-of-concept study.
Journal: Acta pharmacologica Sinica
Published: December 19, 2025
Trefoil Factor-3 Is a Hypoxia-Triggered Pro-Tumorigenic Factor in Hepatoblastoma.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: October 27, 2025
Usefulness of plasma bile acid profile as a prognostic biomarker for drug-induced liver injury.
Journal: EBioMedicine
Published: October 25, 2025
Impact of poly(rC)-binding protein 2 (PCBP2) on the malignant phenotype of cholangiocarcinoma.
Journal: Biochemical pharmacology
Published: October 06, 2025
A three-gene resistome signature as a prognostic tool in hepatocellular carcinoma.
Journal: Annals of hepatology
Published: July 17, 2025
Pharmacological strategies to enhance the response of hepatoblastoma to chemotherapy through MDR1 inhibition.
Journal: Acta pharmacologica Sinica
Published: July 10, 2025
Screening for Mutations Causing ACOX2 Deficiency-associated Hypertransaminasemia in Patients with Cryptogenic Liver Injury.
Journal: Journal of clinical and translational hepatology
Published: July 07, 2025
Drug-Resistant Cholangiocarcinoma Cell Lines for Therapeutic Evaluation of Novel Drugs.
Journal: Molecules (Basel, Switzerland)
Published: June 10, 2025
Bile acids in liver and gastrointestinal cancer.
Journal: Seminars in cancer biology
Published: April 19, 2025
Last Updated: 09/26/2026